Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges

被引:0
作者
Lefkovits, Yael R. [1 ,2 ,3 ]
Heriot, Natalie [2 ]
Sporik, Alice [2 ]
Perera, Sharnel [2 ]
Friedlander, Michael [4 ]
Dixon, Cyril [5 ]
Cohen, Paul A. [6 ,7 ,8 ]
Lee, Yeh Chen [9 ,10 ,11 ]
Hyde, Simon [12 ]
Richardson, Gary [13 ]
Webb, Penelope [14 ]
Rome, Robert [15 ]
King, Madeleine [16 ]
Zalcberg, John [2 ]
Schofield, Penelope [3 ,17 ,18 ,19 ]
机构
[1] Royal Melbourne Hosp, Melbourne, Vic, Australia
[2] Monash Univ, Fac Med, Sch Publ Hlth & Prevent Med, Melbourne, Australia
[3] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[4] Univ New South Wales, Dept Med Oncol, Sydney, Australia
[5] Ovarian Canc Australia, Melbourne, Vic, Australia
[6] Univ Western Australia, Med Sch, Discipline Obstet & Gynaecol, Crawley, WA, Australia
[7] St John God Subiaco Hosp, Dept Gynaecol Oncol, Subiaco, WA, Australia
[8] Univ Notre Dame, Inst Hlth Res, Fremantle, WA, Australia
[9] Prince Wales Hosp, Med Oncol Dept, Randwick, NSW, Australia
[10] Univ New South Wales, Fac Med & Hlth, Randwick, NSW, Australia
[11] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[12] Mercy Hosp Women, Dept Gynaecol Oncol, Heidelberg, Vic, Australia
[13] Cabrini Res, Szalmuk Family Dept Med Oncol, Malvern, Vic, Australia
[14] QIMR Berghofer Med Res Inst, Herston, Qld, Australia
[15] Epworth HealthCare, Clin Inst Obstet & Gynaecol, East Melbourne, Vic, Australia
[16] Univ Sydney, Sch Psychol, Sydney, NSW, Australia
[17] Peter MacCallum Ctr, Hlth Serv Res & Implementat Sci, Behav Sci Unit, Melbourne, Vic, Australia
[18] Swinburne Univ, Iverson Hlth Innovat Res Inst, Dept Psychol, Melbourne, Vic, Australia
[19] Swinburne Univ, Dept Behav Sci Canc, Hawthorn, Vic, Australia
关键词
Patient reported outcome measures; Gynaecological cancer; Clinical quality registry; Ovarian cancer; Quality of life; OF-LIFE; EUROPEAN-ORGANIZATION; FUNCTIONAL ASSESSMENT; HEALTH-CARE; VALIDATION; ONCOLOGY; VALIDITY; TRIALS; NCCN; RELIABILITY;
D O I
10.1186/s12913-024-11042-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
As medical treatment increasingly focuses on improving health-related quality of life, patient-reported outcome measures (PROMs) are an essential component of clinical research. The National Gynae-Oncology Registry (NGOR) is an Australian clinical quality registry. A suitable PROM was required for the NGOR ovarian cancer module to complement clinical outcomes and provide insights into outcomes important to patients. Our narrative review aimed to identify existing ovarian cancer-specific PROMs and ascertain which tool would be most appropriate for implementation into the NGOR ovarian cancer module.A literature review of Cochrane Library, Embase, MEDLINE and PubMed databases was performed to identify existing ovarian cancer-specific PROM tools. A steering committee was convened to (1) determine the purpose of, and criteria for our required PROM; and (2) to review the available tools against the criteria and recommend the most appropriate one for implementation within the NGOR.The literature review yielded five tools: MOST, EORTC QLQ-OV28, FACIT-O, NFOSI-18 and QOL-OVCA. All were developed and validated for use in clinical trials, but none had been validated for use in clinical quality registry. Our expert steering committee pre-determined purpose of a PROM tool for use within the NGOR was to enable cross-service comparison and benchmarking to drive quality improvements. They identified that while there was no ideal, pre-existing, ovarian cancer-specific PROM tool for implementation into the NGOR, on the basis of its psychometric properties, its available translations, its length and its ability to be adapted, the EORTC tool is most fit-for-purpose for integration into the NGOR.This process enabled identification of the tool most appropriate to provide insights into how ovarian cancer treatments impact patients' quality of life and permit benchmarking across health services.
引用
收藏
页数:12
相关论文
共 44 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Towards a strategy for clinical quality registries in Australia
    Ahern, Susannah
    Evans, Sue
    Hopper, Ingrid
    Zalcberg, John
    [J]. AUSTRALIAN HEALTH REVIEW, 2019, 43 (03) : 284 - 287
  • [3] Validation of the Turkish version of European Organization for Research and Treatment of Cancer QLQ-OV28 ovarian cancer specific quality of life questionnaire
    Akdemir, Yesim
    Cam, Cetin
    Ay, Nadiye Pinar
    Karateke, Ates
    [J]. TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 17 (01) : 52 - 57
  • [4] NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
    Armstrong, Deborah K.
    Alvarez, Ronald D.
    Bakkum-Gamez, Jamie N.
    Barroilhet, Lisa
    Behbakht, Kian
    Berchuck, Andrew
    Berek, Jonathan S.
    Chen, Lee-may
    Cristea, Mihaela
    DeRosa, Marie
    ElNaggar, Adam C.
    Gershenson, David M.
    Gray, Heidi J.
    Hakam, Ardeshir
    Jain, Angela
    Leath, Charles A., III
    Liu, Joyce
    Mahdi, Haider
    Matei, Daniela
    McHale, Michael
    McLean, Karen
    O'Malley, David M.
    Penson, Richard T.
    Percac-Lima, Sanja
    Ratner, Elena
    Remmenga, Steven W.
    Sabbatini, Paul
    Werner, Theresa L.
    Zsiros, Emese
    Burns, Jennifer L.
    Engh, Anita M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (08): : 896 - +
  • [5] Australian Commission on Safety and Quality in Health Care, 2014, FRAMEWORK AUSTR CLIN
  • [6] The importance of health-related quality-of-life data in determining the value of drug therapy
    Badia, X
    Herdman, M
    [J]. CLINICAL THERAPEUTICS, 2001, 23 (01) : 168 - 175
  • [7] Reliability and validity of the functional assessment of cancer therapy-ovarian
    Basen-Engquist, K
    Bodurka-Bevers, D
    Fitzgerad, MA
    Webster, K
    Cella, D
    Hu, SH
    Gershenson, DM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1809 - 1817
  • [8] Reporting of Patient-Reported Outcomes in Randomized Trials The CONSORT PRO Extension
    Calvert, Melanie
    Blazeby, Jane
    Altman, Douglas G.
    Revicki, Dennis A.
    Moher, David
    Brundage, Michael D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 814 - 822
  • [9] Development and validation of the measure of ovarian symptoms and treatment concerns for surveillance (MOST-S26): An instrument to complement the clinical follow-up of women with ovarian cancer after completion of first-line treatment
    Campbell, Rachel
    King, Madeleine T.
    Ross, Tanya L.
    Cohen, Paul A.
    Friedlander, Michael L.
    Webb, Penelope M.
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 163 (02) : 398 - 407
  • [10] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE
    CELLA, DF
    TULSKY, DS
    GRAY, G
    SARAFIAN, B
    LINN, E
    BONOMI, A
    SILBERMAN, M
    YELLEN, SB
    WINICOUR, P
    BRANNON, J
    ECKBERG, K
    LLOYD, S
    PURL, S
    BLENDOWSKI, C
    GOODMAN, M
    BARNICLE, M
    STEWART, I
    MCHALE, M
    BONOMI, P
    KAPLAN, E
    TAYLOR, S
    THOMAS, CR
    HARRIS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 570 - 579